Hints and tips:
...“Pfizer and Moderna have kicked off conversations with suppliers like Trilink, Aldevron and New England Biolabs to answer the challenge, but it will require government and deep cross-industry co-operation...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...It has shown broad cross-reactivity against variants, including Omicron. Novavax’s vaccine could also play a significant role in raising coverage rates in poorer countries....
...Last month, Pfizer said it planned to apply for approval of its third dose in August....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...PHE is using a different method to determine whether or not the vaccine is having an impact on case rates in the population, cross-checking Covid-19 testing data with centrally held national vaccination...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...Johnson, who on Sunday celebrated a daily record of 844,285 first and second vaccinations, fears a cross-Channel dispute could spark vaccine protectionism more widely across the globe....
...Pfizer similarly has all of its non-US production situated inside the bloc....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...However, there are many hurdles to cross in the timeline and failure at just one could push it back significantly, people with knowledge of the EMA’s process cautioned....
...article: Vaccines and the dangers of cross-border re-sale / From Dermot Glynn Twyford, Hampshire, UK...
...Finland, Norway and Estonia were among the best performers in Europe, helped by factors including their population structure and relatively low cross-border flows of people....
...Deutsche Bank’s satellite-powered shipping tracker indicates that Chinese economic activity has now stopped contracting, and some economists are predicting a V-shaped recovery....
...On the last Sunday of April 2019, a sleek Gulfstream V jet belonging to Occidental Petroleum touched down at Omaha airport....
...Mr Kulkarni said the sector would become more like “Apple v Samsung”, where biotechs competed on adding generation after generation of features....
...Mr Greene has also worked on many complex M&A deals, including pharmaceutical company Mylan’s pending $50bn combination with Upjohn, a division of Pfizer....
...Retailers will be charged an average of 40 per cent less on purchases made in the European Economic Area using Mastercard, Maestro, Visa, Visa Electron and V-PAY credit and debit cards issued in countries...
...Yamasaki joins from Mizuho Securities where he focused on cross-border M&A and Saito joins from Greenhill & Co....
...WPP will also reduce is planned capex from £400m to v£300m....
...Related links: A message from the dear leader to the stakhanovites — FT AlphavilleShared mobility V.1, USSR edition — FT AlphavilleWhat Hertz tells us about the future of shared mobility — FT AlphavilleMore...
...Dealmaking, much of it cross-border, has been buoyant....
...Bristol-Myers Squibb have dominated the first wave of immunotherapy with their “checkpoint inhibitors”, which release brakes in the immune system so that it can attack tumours, while Roche, AstraZeneca and Pfizer...
...Today it’s a cautionary tale in cross-border and cross-cultural M&A....
...A section of its shareholders are similarly cross. PPG may come back with a fourth offer. But it is unlikely that it will go hostile....
International Edition